HT
PBYI icon

HAP Trading’s Puma Biotechnology PBYI Stock Holding History

HAP Trading’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,000
Closed -$8K – 2241
2020
Q4 		$8K Buy
+32,000
New +$324K ﹤0.01% 1953
2020
Q1 		– Sell
-13,400
Closed -$16K – 1441
2019
Q4 		$16K Buy
+13,400
New +$111K ﹤0.01% 934
2014
Q3 		– Sell
-50,000
Closed -$119K – 1129
2014
Q2 		$119K Buy
+50,000
New +$3.56M ﹤0.01% 630

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HAP Trading's PBYI Position: Q4 2019 in Review

HAP Trading sold out of Puma Biotechnology (PBYI) in Q4 2019, closing a stake of 23,197 shares — an estimated $192K sold.

HAP Trading first reported a position in PBYI in Q2 2014 and held it in 3 quarters. The position peaked at $2.46M in Q2 2018. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • HAP Trading reported no remaining Puma Biotechnology position as of Q4 2019 after selling out during the quarter.
  • HAP Trading sold 23,197 Puma Biotechnology shares in Q4 2019, an estimated $192K.
  • HAP Trading first reported a position in Puma Biotechnology in Q2 2014 and held it in 3 quarters.
  • HAP Trading's Puma Biotechnology position peaked at $2.46M in Q2 2018.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.